Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Negative and Cognitive Symptoms of Schizophrenia

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Language and Cognition

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Longitudinal associations between MRI and cognitive changes in very early MS.

Multiple sclerosis and related disorders·2016

Same author

Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.

Multiple sclerosis and related disorders·2015

Same author

Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).

Arthritis care & research·2012

Same author

Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.

Arthritis care & research·2012

Same author

Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus.

Arthritis care & research·2011

Same author

Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.

Arthritis care & research·2011

Same journal

Sports Neurology.

Neurologic clinics·2026

Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026

Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026

Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026

Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026

Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Cognitive functioning in multiple sclerosis.

Laura J Julian¹

¹Department of Medicine, University of California San Francisco, 3333 California Street, STE 270, San Francisco, CA 94143-0920, USA. laura.julian@ucsf.edu

Neurologic Clinics

|March 29, 2011

Summary

This summary is machine-generated.

Cognitive dysfunction in multiple sclerosis (MS) is reviewed, covering its nature, risk factors, and assessment. This summary also includes pediatric MS cognition and potential interventions for cognitive problems.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: Jun 3, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

Neurology
Neuroscience
Cognitive Science

Background:

Multiple sclerosis (MS) is characterized by diffuse neuropathology impacting cognitive functions.
Cognitive impairment is a significant aspect of MS, affecting various domains.
Understanding risk and protective factors is crucial for managing MS-related cognitive dysfunction.

Purpose of the Study:

To review the nature and course of cognitive dysfunction in MS.
To discuss factors influencing the development of cognitive impairment in MS.
To explore assessment, screening, and intervention strategies for cognitive problems in MS, including pediatric cases.

Main Methods:

Literature review of recent advances in MS neuropathology and cognitive function.
Synthesis of information on risk and protective factors for cognitive impairment.
Discussion of assessment tools and screening approaches for MS-related cognitive dysfunction.
Inclusion of pediatric-onset MS cognition and intervention strategies.

Main Results:

Cognitive dysfunction in MS is linked to diffuse neuropathology.
Specific factors can increase or decrease the risk of cognitive impairment.
Various assessment and screening methods are available for MS-related cognitive issues.
Intervention strategies show promise for treating cognitive problems in MS.

Conclusions:

Cognitive dysfunction is a complex manifestation of MS, influenced by neuropathology and individual factors.
Comprehensive assessment and targeted interventions are essential for managing cognitive impairment in MS patients.
Addressing cognitive issues in both adult and pediatric MS populations is critical for improving quality of life.